Ken Griffin’s Unity Biotechnology UBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Hold
0
7018
2025
Q1
Hold
0
6953
2024
Q4
Sell
-69,210
Closed -$102K 6801
2024
Q3
$102K Sell
69,210
-2,998
-4% -$4.41K ﹤0.01% 4913
2024
Q2
$97.5K Sell
72,208
-21,383
-23% -$28.9K ﹤0.01% 4964
2024
Q1
$153K Buy
93,591
+44,915
+92% +$73.7K ﹤0.01% 4906
2023
Q4
$93.9K Buy
+48,676
New +$93.9K ﹤0.01% 4895
2023
Q3
Sell
-1,673
Closed -$4.27K 6524
2023
Q2
$4.27K Sell
1,673
-920
-35% -$2.35K ﹤0.01% 5479
2023
Q1
$4.23K Sell
2,593
-31,527
-92% -$51.4K ﹤0.01% 5626
2022
Q4
$93.5K Buy
34,120
+22,787
+201% +$62.4K ﹤0.01% 5046
2022
Q3
$45K Buy
11,333
+2,267
+25% +$9K ﹤0.01% 5355
2022
Q2
$51K Buy
9,066
+3,207
+55% +$18K ﹤0.01% 5498
2022
Q1
$66K Sell
5,859
-4,123
-41% -$46.4K ﹤0.01% 5812
2021
Q4
$146K Buy
9,982
+7,728
+343% +$113K ﹤0.01% 5679
2021
Q3
$67K Sell
2,254
-2,966
-57% -$88.2K ﹤0.01% 6029
2021
Q2
$242K Sell
5,220
-5,217
-50% -$242K ﹤0.01% 5403
2021
Q1
$627K Buy
10,437
+5,644
+118% +$339K ﹤0.01% 4370
2020
Q4
$251K Buy
4,793
+1,330
+38% +$69.6K ﹤0.01% 4363
2020
Q3
$120K Sell
3,463
-10,485
-75% -$363K ﹤0.01% 4215
2020
Q2
$1.21M Sell
13,948
-5,574
-29% -$484K ﹤0.01% 2688
2020
Q1
$1.13M Sell
19,522
-17,139
-47% -$994K ﹤0.01% 2745
2019
Q4
$2.64M Sell
36,661
-526
-1% -$37.9K ﹤0.01% 2117
2019
Q3
$2.27M Buy
37,187
+13,348
+56% +$814K ﹤0.01% 2268
2019
Q2
$2.27M Buy
23,839
+19,497
+449% +$1.85M ﹤0.01% 2314
2019
Q1
$352K Buy
+4,342
New +$352K ﹤0.01% 3617
2018
Q3
Sell
-1,522
Closed -$230K 4727
2018
Q2
$230K Buy
+1,522
New +$230K ﹤0.01% 3598